CL
REGN icon

CPWM LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

CPWM LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-629
Closed -$309K – 248
2017
Q2 		$309K Sell
629
-6
-0.9% -$2.63K 0.07% 184
2017
Q1 		$246K Sell
635
-49
-7% -$18.2K 0.06% 203
2016
Q4 		$251K Sell
684
-71
-9% -$27K 0.06% 207
2016
Q3 		$304K Buy
755
+13
+2% +$5.21K 0.07% 197
2016
Q2 		$259K Buy
742
+115
+18% +$44.3K 0.06% 218
2016
Q1 		$226K Sell
627
-125
-17% -$51.5K 0.05% 238
2015
Q4 		$408K Buy
+752
New +$407K 0.08% 166

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CPWM LLC's REGN Position: Q3 2017 in Review

CPWM LLC sold out of Regeneron Pharmaceuticals (REGN) in Q3 2017, closing a stake of 629 shares — an estimated $309K sold.

CPWM LLC first reported a position in REGN in Q4 2015 and held it in 7 quarters. The position peaked at $408K in Q4 2015. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

  • CPWM LLC reported no remaining Regeneron Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • CPWM LLC sold 629 Regeneron Pharmaceuticals shares in Q3 2017, an estimated $309K.
  • CPWM LLC first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 7 quarters.
  • CPWM LLC's Regeneron Pharmaceuticals position peaked at $408K in Q4 2015.
  • 605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on CPWM LLC's 13F filing for Q3 2017, filed 14 Nov 2017.